We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Beactica

News List

Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug prnasia
March 02, 2021
Oscotec Inc., the Korean drug development company, and Beactica Therapeutics AB, the Swedish drug discovery company, today announced a new research development and licensing agreement.
Sanofi extends master services agreement with Beactica pharmaceutical-technology
June 01, 2018
Sanofi has extended its master services agreement with Swedish drug discovery firm Beactica to characterise the interactions between new therapeutics and their target proteins.
Beactica Announces Glioblastoma Research Collaboration with Uppsala University and the DDD Platform b3cnewswire
May 17, 2017
Beactica AB announced a new research collaboration with Uppsala University and the Drug Discovery and Development Platform at SciLifeLab to study the effects on brain cancer stem cells of specific small molecules under development by Beactica.